Wade’s Health Law Highlights for August 11, 2026
Read the issue: Wade’s Health Law Highlights for August 11, 2026False Claims Act settlements and judgments announced in the first half of 2026 total more than $1.8 billion The total includes two nine-figure Medicare Advantage resolutions and a customs duties settlement exceeding half a billion dollars, the largest of its kind. As…
Recent issues
Post-Chevron Health Care Regulations: The Dawn of a New Day
Summary of article from ArentFox Schiff, by Douglas a. Grimm, Lowell C. Brown, David S. Greenberg, Pascal Naples: The Supreme Court’s decision in Loper Bright Enterprises…
An Introduction to Healthcare AI Innovation in an Evolving Regulatory Landscape
Summary of article from Benesch, by Arielle Lester, Vince Nardone, Amanda Ray, Kathrin Zaki: The expansion of AI applications in healthcare is revolutionizing the industry, enhancing…
The Limits of AI in Healthcare: Exploring Ethical and Practical Challenges
Summary of article from Nelson Hardiman, LLP, by Harry Nelson: The integration of AI in healthcare, exemplified by companies like RealtimeMed and initiatives such as Eureka…
False Claims Act Settlements to Know from Q2 2024
Summary of article from Bass, Berry & Sims PLC, by Latazia Carter, Scott Gallisdorfer: In Q2 2024, the Department of Justice announced significant False Claims Act…
OCR Settles Alleged HIPAA Violations for $950,000 Following 2017 Ransomware Attack
Summary of article from King & Spalding, by Elizabeth Kimball Key: On July 1, 2024, the HHS Office of Civil Rights (OCR) announced that Heritage Valley…
CMS’ First No Surprises Audit Targets Aetna, Finds Some Noncompliance
Summary of article from Healthcare Dive, by Rebecca Pifer: The CMS’ first audit under the No Surprises Act found Aetna in Texas noncompliant with several key…
Addressing Patient Transportation Needs
Summary of article from Dentons, by Susan Freed: A significant barrier to accessing healthcare services is the lack of transportation, with one in five patients forgoing…
OIG Issues Favorable Advisory Opinion Involving Financial Risk Mitigation Arrangements for High-Cost Rare Disease Drug
Summary of article from Arnall Golden Gregory LLP, by David Blank: On June 20, 2024, the U.S. Department of Health and Human Services Office of Inspector…
FTC to Sue Drug Middlemen Over Insulin Prices, Source Says
Summary of article from Reuters, by Jody Godoy, Mariam E Sunny: The U.S. Federal Trade Commission (FTC) plans to sue UnitedHealth, Cigna, and CVS Health over…